Intarcia: Implantable Diabetes Drug-Device Combo From Intarcia Gets Public Hearing

Intarcia Therapeutics will continue its seven-year quest for FDA approval of its drug-device diabetes treatment with an alternative form of hearing - a public hearing before an advisory committee on [...]